The Patent Finder

Personal Genome Diagnostics Inc.

12 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Feb 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 23, 2026
    The maintenance fee for Selective Capture of Target DNA Sequences (US 11,655,503) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Neoantigen Treatment Prioritization Using Multivariate Analysis Based on: Hla Genotype, Self-Similarity, Similarity to Known Antigens, Antigen Expression Levels and Mutant Allele Frequency (US 10,563,266) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Machine Learning System and Method for Somatic Mutation Discovery (US 11,972,841) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,544,473Nucleic Acid Analysis Using Sequence Tokens
In force
 · High confidence
In forceHigh confidence
US 8,021,842Nucleic Acid Analysis Using Sequence Tokens
In force
 · High confidence
In forceHigh confidence
US 10,927,408Method for Evaluating Minority Variants in a Sample
In force
 · High confidence
In forceHigh confidence
US 10,563,266Neoantigen Treatment Prioritization Using Multivariate Analysis Based on: Hla Genotype, Self-Similarity, Similarity to Known Antigens, Antigen Expression Levels and Mutant Allele Frequency
In force
 · High confidence
In forceHigh confidence
US 11,597,967Process for Microsatellite Instability Detection
In force
 · High confidence
In forceHigh confidence
US 12,497,661Method of Improving Prediction of Response for Cancer Patients Treated with Immunotherapy
In force
 · High confidence
In forceHigh confidence
US 12,331,361Methods and Systems for Identification and Prioritization of Mutation-Derived Neoantigens
In force
 · Medium confidence
In forceMedium confidence
US 11,655,503Selective Capture of Target DNA Sequences
In force
 · High confidence
In forceHigh confidence
US 11,972,841Machine Learning System and Method for Somatic Mutation Discovery
In force
 · High confidence
In forceHigh confidence
US 12,655,463Compositions and Methods for Nucleic Acid Quality Determination
In force
 · High confidence
In forceHigh confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
Also on record, not counted in the 12: 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 4 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited